BIOSYSTEMS ENGINEERING, published by Academic Press Inc. Elsevier Science, is a leading journal that has established itself as a key contributor in the fields of agronomy, crop science, animal science, food science, soil science, and control systems engineering. With an impressive position in the 2023 Category Quartiles, featuring Q1 rankings in Agronomy and Crop Science, Animal Science and Zoology, Food Science, and Soil Science, alongside a Q2 ranking in Control and Systems Engineering, this journal stands at the forefront of innovative research. Currently indexed in Scopus, it boasts a commendable track record, with its Agricultural and Biological Sciences rankings placing it in the 95th percentile for Agronomy and Crop Science and the 90th percentile for Soil Science, among others. With a commitment to disseminating critical advancements and fostering scientific dialogue, BIOSYSTEMS ENGINEERING offers an invaluable platform for researchers, professionals, and students alike, seeking to advance their understanding and application of engineering principles in biological systems. As a hybrid journal that provides both subscription and open access options, it ensures broad accessibility to high-quality research that shapes the future of sustainable agriculture and biological systems.

CRITICAL REVIEWS IN PLANT SCIENCES, published by Taylor & Francis Inc, is a prestigious journal that has been advancing the field of plant science since its inception in 1983. With an impressive impact factor and consistently ranked in the top quartile (Q1) of its category, this journal is a leading platform for the dissemination of peer-reviewed research that spans the breadth of plant biology, ecology, and agricultural applications. Housed in the United Kingdom, it serves an international readership, making significant contributions to our understanding of plant systems and their environmental interactions. This journal is highly regarded within the Scopus rankings, holding an impressive position of 18 out of 516 journals in the Agriculture and Biological Sciences category, placing it in the 96th percentile. Although not currently open access, the journal provides valuable insights and critical reviews that are essential for researchers, professionals, and students striving to further their knowledge and bolster their own research in plant sciences.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY is a prestigious academic journal dedicated to advancing the field of pharmaceutical biotechnology by publishing high-quality research articles, reviews, and innovatory methodologies. Published by Bentham Science Publishers Ltd, this journal has established a strong reputation in its field, reflected in its 2023 Scopus rankings: it holds an impressive Q2 classification in Pharmaceutical Science and Q3 in Biotechnology, indicating its significant impact within these disciplines. With an ISSN of 1389-2010 and an E-ISSN of 1873-4316, CURRENT PHARMACEUTICAL BIOTECHNOLOGY provides a reliable platform for disseminating valuable research findings and fostering collaboration among researchers, professionals, and students alike. The journal covers a wide array of topics, from drug development and delivery systems to innovative biotechnological techniques, thus serving as an essential resource for anyone interested in the cross-section of pharmaceutical science and biotechnology. Researchers can access a diverse range of articles that explore both theoretical frameworks and practical applications, reflecting the ongoing evolution and challenges in this dynamic field.

BIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.

BIOTECHNOLOGY PROGRESS, a prominent journal published by Wiley, stands at the forefront of the biotechnology field, delivering cutting-edge research and emerging trends since its inception in 1985. With an ISSN of 8756-7938 and an E-ISSN of 1520-6033, this journal has carved out a significant niche within the academic community, reflected in its Q2 ranking within the Biotechnology category for 2023. Maintaining a strong presence in the Scopus database, it ranks #111 out of 311 in the categories of Biochemistry, Genetics, and Molecular Biology, demonstrating its commitment to quality and significance in the field. Although it does not offer open access, it remains accessible through various institutional subscriptions, ensuring that vital biological and biotechnological discoveries reach a broad audience, including researchers, professionals, and students. Given its rigorous peer-review process and a focus on innovative methodologies, BIOTECHNOLOGY PROGRESS is an indispensable resource for anyone looking to stay informed about the latest advancements and applications in biotechnology.

PLANTA, published by SPRINGER, stands as a pivotal journal in the field of plant sciences and genetics, known for its rigorous peer-reviewed research that has influenced the advancement of botanical science since its inception in 1925. With an impressive trajectory of convergence from the years 1925 to 1945, and again from 1947 to 2024, this journal maintains a strong reputation, currently categorized in the prestigious Q1 tier of Plant Science and Q2 tier in Genetics as of 2023. The journal is recognized for its high impact, ranked #64 out of 516 in Plant Science by Scopus, representing the top 87th percentile within its category, while also securing a strong position in Genetics with a #92 rank. The journal serves as a critical resource for researchers, professionals, and students who are eager to explore the complex genetics, biochemistry, and evolutionary biology of plants. Though primarily subscription-based, the quality of the research published in PLANTA makes it an essential reading for anyone serious about advancing their knowledge and understanding of plant sciences.

Research Journal of Biotechnology is a premier publication dedicated to advancing the field of biotechnology through the dissemination of impactful research articles. Published by Research Journal Biotechnology in India, this journal operates under an Open Access model, facilitating unrestricted access to high-quality research for researchers, professionals, and students worldwide. With an ISSN of 2278-4535 and an E-ISSN of 2278-4535, the journal aims to serve as a comprehensive platform for innovative studies in Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology. Despite its current Q4 quartile ranking in these categories, the journal aspires to extend its influence and visibility in the academic community, aiming for greater impact in the future. The journal features research articles that span a wide array of topics in biotechnology, fostering a collaborative and knowledge-rich environment for national and international scholars. We invite you to explore, contribute to, and engage with the expanding landscape of biotechnological research through the Research Journal of Biotechnology.

MOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.

Synthetic and Systems Biotechnology, published by KEAI PUBLISHING LTD, is a pioneering open-access journal that has made significant contributions to the fields of applied microbiology, biotechnology, biomedical engineering, genetics, and structural biology since its inception in 2016. With an ISSN of 2405-805X, this journal is committed to fostering innovative research and interdisciplinary collaboration, providing a platform for the dissemination of high-quality studies that push the boundaries of scientific knowledge. Recognized for its excellence, it holds prestigious Q1 rankings in both Applied Microbiology and Biotechnology as well as Biomedical Engineering in 2023, alongside notable Q2 rankings in Genetics and Structural Biology. Researchers, professionals, and students alike can access cutting-edge research that explores the dynamic interplay between synthetic biology and systems biology, driving advancements that could reshape health, industry, and environmental sustainability. By operating under an open-access model, Synthetic and Systems Biotechnology ensures that new findings are accessible to a global audience, thereby maximizing the impact and reach of the published work and paving the way for future discoveries.

ANIMAL BIOTECHNOLOGY is a premier journal published by Taylor & Francis Inc, dedicated to fostering innovative research in the field of animal biotechnology. With an ISSN of 1049-5398 and an E-ISSN of 1532-2378, this journal has established itself as a significant platform for scholars and professionals looking to advance their understanding of biotechnological applications in animal science. Since its inception in 1990, ANIMAL BIOTECHNOLOGY has garnered attention, currently ranking in the Q2 category for Animal Science and Zoology and Q3 in both Bioengineering and Biotechnology, reflecting its valuable contributions to these evolving fields. Researchers looking to publish their work can benefit from the journal's esteemed reputation, further emphasized by its Scopus rankings, which place it in the top tiers of relevant categories. While the journal does not currently offer open access, its essential body of knowledge serves as a crucial resource for anyone involved in animal biotechnological research, including academics, industry professionals, and students aiming to deepen their expertise and drive innovation within this exciting domain.